Key facts
- President Trump has proposed tariffs on imported drugs.
- The stated goal of these tariffs is to lower drug prices in the U.S.
- India is a significant global exporter of generic pharmaceuticals.
- The proposed tariffs could challenge India's role as the 'pharmacy of the world'.
President Trump's administration has put forth proposals for tariffs on imported drugs, a move intended to drive down prescription medication costs within the United States. This policy shift carries significant implications for India, a country that has established itself as a leading global supplier of generic pharmaceuticals, often referred to as the 'pharmacy of the world'. The potential imposition of these tariffs raises questions about the future of India's dominant position in the global drug market, as it could disrupt established supply chains and alter international trade dynamics in the pharmaceutical sector.